Press release
Hypertriglyceridemia Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Ionis Pharma, 89bio, Inc., Arrowhead Pharma, Hightide Therapeutics, Eli Lilly
DelveInsight's "Hypertriglyceridemia Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Hypertriglyceridemia, historical and forecasted epidemiology as well as the Hypertriglyceridemia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Hypertriglyceridemia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Hypertriglyceridemia Market Forecast [https://www.delveinsight.com/sample-request/hypertriglyceridemia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Hypertriglyceridemia Market Report:
* The Hypertriglyceridemia market size was valued approximately USD 2,400 million in 2022 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
* In November 2023, During the American Heart Association (AHA) Scientific Sessions 2023 in Philadelphia, USA, Arrowhead Pharmaceuticals presented Phase II clinical data for plozasiran (ARO-APOC3) and zodasiran (ARO-ANG3). Results from the Phase II SHASTA-2 study revealed that plozasiran led to significant reductions, including a decrease in APOC3 by 79%, triglycerides (TG) by 74%, and remnant cholesterol by 65%, while increasing high-density lipoprotein (HDL)-cholesterol (HDL-C) by 68% at 24 weeks among patients with severe hypertriglyceridemia.
* According to DelveInsight's analysis, the diagnosed prevalent cases of hypertriglyceridemia in the 7MM were estimated to be around 69,607,255 in 2022. Projections suggest that these numbers are likely to rise during the forecast period.
* In 2022, the total diagnosed prevalent cases of severe hypertriglyceridemia in the 7MM were noted to be 3,480,363. There was a notable compound annual growth rate (CAGR) observed during the study period from 2019 to 2032.
* In the European region, Germany had the largest diagnosed prevalent population of severe hypertriglyceridemia (SHTG) with 364,734 cases in 2022, followed by the UK with 278,983 cases. Conversely, Spain had the lowest diagnosed prevalent population.
* The Hypertriglyceridemia pipeline includes significant assets such as Olezarsen (ApoC-III), ARO-APOC3, Pegozafermin (BIO89-100), and others. These promising candidates, upon successful launch, are expected to drive market growth during the forecast period.
* Key Hypertriglyceridemia Companies: Ionis Pharmaceuticals, 89bio, Inc., Arrowhead Pharmaceuticals, Inc., Hightide Therapeutics, Eli Lilly and Company, OrsoBio, Marea Therapeutics, NorthSea Therapeutics, and others
* Key Hypertriglyceridemia Therapies: Olezarsen, Pegozafermin (BIO89-100), ARO-APOC3, HTD1801, LY3875383, TLC-2716, MAR001, NST-1024, and others
* The Hypertriglyceridemia epidemiology based on gender analyzed that the severityspecific data reveal the highest number of cases were observed in moderate level of Hypertriglyceridemia
* The Hypertriglyceridemia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Hypertriglyceridemia pipeline products will significantly revolutionize the Hypertriglyceridemia market dynamics.
Hypertriglyceridemia Overview
Hypertriglyceridemia is a condition characterized by elevated levels of triglycerides in the blood. Triglycerides are a type of fat found in the bloodstream and stored in fat cells. When levels of triglycerides are too high, it can increase the risk of various health complications, including cardiovascular disease, pancreatitis, and metabolic syndrome.
Get a Free sample for the Hypertriglyceridemia Market Forecast, Size & Share Analysis Report:
delveinsight.com/report-store/hypertriglyceridemia-market [http://delveinsight.com/report-store/hypertriglyceridemia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Hypertriglyceridemia Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Hypertriglyceridemia Epidemiology Segmentation:
The Hypertriglyceridemia market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
* Total Prevalence of Hypertriglyceridemia
* Prevalent Cases of Hypertriglyceridemia by severity
* Gender-specific Prevalence of Hypertriglyceridemia
* Diagnosed Cases of Episodic and Chronic Hypertriglyceridemia
Download the report to understand which factors are driving Hypertriglyceridemia epidemiology trends @ Hypertriglyceridemia Epidemiology Forecast [https://www.delveinsight.com/sample-request/hypertriglyceridemia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Hypertriglyceridemia Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Hypertriglyceridemia market or expected to get launched during the study period. The analysis covers Hypertriglyceridemia market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Hypertriglyceridemia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Hypertriglyceridemia Therapies and Key Companies
* Olezarsen: Ionis Pharmaceuticals
* Pegozafermin (BIO89-100): 89bio, Inc.
* ARO-APOC3: Arrowhead Pharmaceuticals, Inc.
* HTD1801: Hightide Therapeutics
* LY3875383: Eli Lilly and Company
* TLC-2716: OrsoBio
* MAR001: Marea Therapeutics
* NST-1024: NorthSea Therapeutics
Discover more about therapies set to grab major Hypertriglyceridemia market share @ Hypertriglyceridemia Treatment Landscape [https://www.delveinsight.com/sample-request/hypertriglyceridemia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Hypertriglyceridemia Market Drivers
* The increasing prevalent population and increasing episodes of primary and secondary causes worldwide are likely to cause a surge in treatment options. Consequently, the market will witness a boost in the upcoming year.
Hypertriglyceridemia Market Barriers
* Medications with better safety and effectiveness, which provide an optimum cure, are the current unmet need of the SHTG disease market.
Scope of the Hypertriglyceridemia Market Report
* Study Period: 2019-2032
* Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
* Key Hypertriglyceridemia Companies: Ionis Pharmaceuticals, 89bio, Inc., Arrowhead Pharmaceuticals, Inc., Hightide Therapeutics, Eli Lilly and Company, OrsoBio, Marea Therapeutics, NorthSea Therapeutics, and others
* Key Hypertriglyceridemia Therapies: Olezarsen, Pegozafermin (BIO89-100), ARO-APOC3, HTD1801, LY3875383, TLC-2716, MAR001, NST-1024, and others
* Hypertriglyceridemia Therapeutic Assessment: Hypertriglyceridemia current marketed and Hypertriglyceridemia emerging therapies
* Hypertriglyceridemia Market Dynamics: Hypertriglyceridemia market drivers and Hypertriglyceridemia market barriers
* Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
* Hypertriglyceridemia Unmet Needs, KOL's views, Analyst's views, Hypertriglyceridemia Market Access and Reimbursement
To know more about Hypertriglyceridemia companies working in the treatment market, visit @ Hypertriglyceridemia Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/hypertriglyceridemia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Hypertriglyceridemia Market Report Introduction
2. Executive Summary for Hypertriglyceridemia
3. SWOT analysis of Hypertriglyceridemia
4. Hypertriglyceridemia Patient Share (%) Overview at a Glance
5. Hypertriglyceridemia Market Overview at a Glance
6. Hypertriglyceridemia Disease Background and Overview
7. Hypertriglyceridemia Epidemiology and Patient Population
8. Country-Specific Patient Population of Hypertriglyceridemia
9. Hypertriglyceridemia Current Treatment and Medical Practices
10. Hypertriglyceridemia Unmet Needs
11. Hypertriglyceridemia Emerging Therapies
12. Hypertriglyceridemia Market Outlook
13. Country-Wise Hypertriglyceridemia Market Analysis (2019-2032)
14. Hypertriglyceridemia Market Access and Reimbursement of Therapies
15. Hypertriglyceridemia Market Drivers
16. Hypertriglyceridemia Market Barriers
17. Hypertriglyceridemia Appendix
18. Hypertriglyceridemia Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=hypertriglyceridemia-market-to-observe-impressive-growth-during-the-forecast-period-20232032-evaluates-delveinsight-ionis-pharma-89bio-inc-arrowhead-pharma-hightide-therapeutics-eli-lilly]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hypertriglyceridemia Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Ionis Pharma, 89bio, Inc., Arrowhead Pharma, Hightide Therapeutics, Eli Lilly here
News-ID: 3468936 • Views: …
More Releases from ABNewswire
Preserving Precious Memories: The Art of Crafting Custom Family Portraits
In an era where digital technology dominates our daily lives, the timeless tradition of custom family portraits continues to thrive, offering a unique blend of personal touch and artistic flair to preserve life's most cherished moments. These portraits, often painted or crafted by skilled artists, serve as more than just decorative pieces; they are profound representations of familial bonds and heritage, encapsulating the essence of loved ones in a way…
Paroxysmal Nocturnal Hemoglobinuria Market is Expected to Expand at a Healthy Gr …
The Paroxysmal Nocturnal Hemoglobinuria Market size was valued approximately USD 11 billion in 2021 and the report offers an in-depth understanding of the Paroxysmal Nocturnal Hemoglobinuria, historical and forecasted epidemiology as well as the Paroxysmal Nocturnal Hemoglobinuria market trends in the 7MM.
DelveInsight's "Paroxysmal Nocturnal Hemoglobinuria Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Paroxysmal Nocturnal Hemoglobinuria, historical and forecasted epidemiology as well as the Paroxysmal…
Immune Thrombocytopenia Purpura Market to Observe Impressive Growth During the F …
The Immune Thrombocytopenia Purpura Market size was valued approximately USD 3,160 million in 2022 and the report offers an in-depth understanding of the Immune Thrombocytopenia Purpura, historical and forecasted epidemiology as well as the Immune Thrombocytopenia Purpura market trends in the 7MM.
DelveInsight's "Immune Thrombocytopenia Purpura Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Immune Thrombocytopenia Purpura, historical and forecasted epidemiology as well as the Immune…
Cold Agglutinin Disease Market to Exhibit Rapid Growth Rate During the Forecast …
The Cold Agglutinin Disease Market report offers an in-depth understanding of the Cold Agglutinin Disease, historical and forecasted epidemiology as well as the Cold Agglutinin Disease market trends in the 7MM.
DelveInsight's "Cold Agglutinin Disease Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Cold Agglutinin Disease, historical and forecasted epidemiology as well as the Cold Agglutinin Disease market trends in the United States, EU4 (Germany, Spain,…
More Releases for Hypertriglyceridemia
Severe Hypertriglyceridemia Pipeline Assessment - FDA, EMA, and PMDA Approvals, …
Severe Hypertriglyceridemia pipeline constitutes 10+ key companies continuously working towards developing 10+ Severe Hypertriglyceridemia treatment therapies, analyzes DelveInsight
Hypertriglyceridemia refers to a fasting plasma triglyceride measurement that is increased, typically above the 95th percentile for age and sex- although additional quantitative or qualitative lipoprotein abnormalities can also be present. Patients can fluctuate between hypertriglyceridemic states: given an appropriate metabolic stress, mild or moderate hypertriglyceridemia can deteriorate into severe hypertriglyceridemia.
"Severe Hypertriglyceridemia…
Hypertriglyceridemia Therapeutics Market 2022 Analysis by Growth Revenue, Develo …
Coherent Market Insights provides an encyclopedic study of the Hypertriglyceridemia Therapeutics Market with holistic insights into important factors and aspects impacting the future growth of the market. The Hypertriglyceridemia Therapeutics Market has been analyzed for the forecast period 2022-2028 and the historical period 2016-2021. To help players gain a thorough understanding of the Hypertriglyceridemia Therapeutics Market and its critical dynamics, the research study provides detailed qualitative and quantitative analysis.
The report…
Hypertriglyceridemia-Pipeline Service Market Size 2021 by Product Sales, Revenue …
This report on The Hypertriglyceridemia-Pipeline Service Market is segmented into sections that provides information on the historical and present patient pool as well as the projected trend for each of the seven major nations. It examines various research and the perspectives of important opinion leaders to assist in identifying the reasons for present and anticipated trends. In this section of report, find the diagnosed patient pool, their patterns, and the…
Hypertriglyceridemia Treatment market: How leading companies can make this smart …
The Hypertriglyceridemia Treatment Market is required to display a quickly expanding development rate during the Forecast Period.["In spite of the epidemic subverting worldwide economic situations, the Global Hypertriglyceridemia Treatment market is foreseen to report healthy CAGR in the near Future"]. A few factors, for example, global demand, technology advancements, industrialization, and urbanizations have been supporting business sector improvement throughout the most recent decade.
This Hypertriglyceridemia Treatment market report work with respect…
Hypertriglyceridemia Treatment Market: Global Market Size, Industry Trends, Lead …
OMR recently published new report titled "Hypertriglyceridemia Treatment Market -global trends, market share, industry size, growth, opportunities, and market forecast - 2019-2025" to its portfolio. This latest industry research study analyses the Hypertriglyceridemia TreatmentMarket by different segments, companies, and regions.
Request a free sample of our report on Hypertriglyceridemia Treatment Market: https://www.orionmarketreports.com/hypertriglyceridemia-treatment-market/1345/#ert_pane1-1
Hypertriglyceridemia Treatment Market research report includes the depth analysis of each segment from 2018 to 2025 considering 2018 as the…
Lipid Disorder Treatment Market Size by Drug Type (Pravastatin, Simvastatin), by …
The Lipid Disorder Treatment Market 2019 industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years. Further, justification for the estimates for each segments, and regions will also be provided in qualitative form.
You can get a sample copy of this report at https://www.orianresearch.com/request-sample/1371292
Lipid disorder includes a broad range of metabolic conditions that affect lipid levels in the blood. Lipid disorders…
